Loading…
Aclarion, Inc. is projected to rise to $3.21 by 2027, a +13% move from its current price of $2.69. ACON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/14/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 15 | $2.60 | $2.69 | $2.78 | +0.05% |
| Jul 16 | $2.57 | $2.69 | $2.82 | +0.10% |
| Jul 17 | $2.54 | $2.69 | $2.85 | +0.15% |
| Jul 18 | $2.52 | $2.70 | $2.88 | +0.21% |
| Jul 19 | $2.50 | $2.70 | $2.90 | +0.26% |
| Jul 20 | $2.49 | $2.70 | $2.93 | +0.31% |
| Jul 21 | $2.47 | $2.70 | $2.95 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.47 | $2.70 | $2.95 | +0.36% |
| Week 2 | $2.39 | $2.71 | $3.07 | +0.72% |
| Week 3 | $2.34 | $2.72 | $3.16 | +1.08% |
| Week 4 | $2.29 | $2.73 | $3.25 | +1.45% |
| Week 5 | $2.25 | $2.74 | $3.33 | +1.81% |
| Week 6 | $2.22 | $2.75 | $3.41 | +2.18% |
| Week 7 | $2.19 | $2.76 | $3.48 | +2.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aclarion, Inc. (ACON) is a healthcare technology company in the United States that uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.
The company also provides NOCISCAN MRS Exam Protocol, a software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs, and imaging data transfer products, including AMBRA Healthcare. The NOCISCAN Post-Processor Suite comprises NOCICALC, a Class I medical device that post-processes NOCISCAN MRS data into final spectra and calculates degenerative pain biomarkers, and NOCIGRAM, which converts NOCICALC results into NOCISCORES on a 0-10 scale. The company was formerly Nocimed, Inc.
and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
ACON is a healthcare technology stock currently trading at $2.84 with a market cap of $7M and a rank of 5187. The stock sits in a near-term technical setup that shows a neutral posture, with a 30-day price range between $2.29 and $3.54. The current price and market indicators suggest a cautious outlook in the short run while longer-term forecasts point to a potential uptrend beginning in the 2030s.
A major floor 18.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 32.7% above — a clean break opens room to run.
A major ceiling 45.0% above — clearing it would confirm fresh momentum.
Key ACON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.95 | Sell | $2.92 | Sell |
| MA 10 | $2.95 | Sell | $2.95 | Sell |
| MA 20 | $2.97 | Sell | $3.00 | Sell |
| MA 50 | $3.15 | Sell | $3.13 | Sell |
| MA 100 | $3.16 | Sell | $4.76 | Sell |
| MA 200 | $4.61 | Sell | $204.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.17 | Neutral |
| Stoch RSI (14) | 44.50 | Neutral |
| CCI (20) | -76.62 | Neutral |
| Williams %R (14) | -64.74 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.59 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 35.26 | Neutral |
| TRIX (15) | -0.38 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 42.64 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 2.90 | Sell |
| ADX (14) | 14.14 | Neutral |
| ATR (14) | 0.07 | Info |
The near-term technical picture is neutral. The RSI(14) is 40, indicating muted momentum. The 50-day simple moving average is $3.15 and the 200-day simple moving average is $4.61, placing the current price below both averages. Support is identified at $2.71 and resistance at $3.57, framing a near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.36 | $2.84 | $3.65 | 0% | Neutral | |
| $2.50 | $3.21 | $4.38 | +13% | Neutral | |
| $2.36 | $3.13 | $4.47 | +10% | Neutral | |
| $2.17 | $2.96 | $4.37 | +4% | Neutral | |
| $1.96 | $2.75 | $4.17 | -3% | Neutral | |
| $2.05 | $2.94 | $4.57 | +3% | Neutral | |
| $2.26 | $3.32 | $5.27 | +17% | Neutral | |
| $2.44 | $3.66 | $5.93 | +29% | Bullish | |
| $2.59 | $3.96 | $6.53 | +39% | Bullish | |
| $2.42 | $3.77 | $6.32 | +32% | Bullish | |
| $3.20 | $5.43 | $9.79 | +91% | Bullish | |
| $3.54 | $7.00 | $13.97 | +146% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.36 | $2.84 | $3.46 | +5.72% |
| August 2026 | $2.37 | $2.82 | $3.44 | -0.96% |
| September 2026 | $2.36 | $2.82 | $3.49 | +0.08% |
| October 2026 | $2.43 | $2.93 | $3.67 | +3.91% |
| November 2026 | $2.41 | $2.92 | $3.69 | -0.32% |
| December 2026 | $2.34 | $2.86 | $3.65 | -2.06% |
Click any year to see its month-by-month ACON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aclarion, Inc.'s 2026 outlook centres on $2.84, within a $2.36 to $3.65 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ACON could reach as high as $4.38, with a base case around $3.21 and support toward $2.50 — roughly +13% from $2.69. A consolidation phase looks the most probable path here.
Expect ACON to range from $2.36 to $4.47 through 2028. The $3.13 average target implies a +10% move from current prices. That is -2% versus the projected 2027 average. Price action looks broadly range-bound.
The ACON price prediction for 2029 points to an average of $2.96 (low $2.17, high $4.37) — a potential gain of +4% on today's $2.69. A consolidation phase looks the most probable path here.
In 2030, ACON is projected to trade between $1.96 and $4.17, averaging $2.75 — a potential decline of -3% from today's $2.69. That is -7% versus the projected 2029 average. Price action looks broadly range-bound.
Aclarion, Inc.'s 2031 outlook centres on $2.94, within a $2.05 to $4.57 range. That is up +7% on the projected 2030 average. That marks a +3% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, ACON could reach as high as $5.27, with a base case around $3.32 and support toward $2.26 — roughly +17% from $2.69. Price action looks broadly range-bound.
Expect ACON to range from $2.44 to $5.93 through 2033. The $3.66 average target implies a +29% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ACON price prediction for 2034 points to an average of $3.96 (low $2.59, high $6.53) — a potential gain of +39% on today's $2.69. Momentum favours further upside here.
In 2035, ACON is projected to trade between $2.42 and $6.32, averaging $3.77 — a potential gain of +32% from today's $2.69. That is -5% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Aclarion, Inc.'s 2040 outlook centres on $5.43, within a $3.20 to $9.79 range. That is up +44% on the projected 2035 average. That marks a +91% change versus current levels. Momentum favours further upside here.
By 2050, ACON could reach as high as $13.97, with a base case around $7.00 and support toward $3.54 — roughly +146% from $2.69. Buyers look set to stay in control over this stretch.
Investing $1,000 in ACON today (≈ 371.747212 ACON) could be worth
$2,603.73
+$1,603.73 (+160%) by 2050 · US Dollar
Based on the average projected ACON price of $7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACONwould be worth at today's price.
$1,000 invested in ACON on Jul 10, 2025 (≈ 135.336312 ACON) would be worth
$364.05
-$635.95 (-63.6%) today · 0.36× · US Dollar
Based on a ACON entry price of $7.39 vs. today's $2.69.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.09 | $870.55 | -12.9% |
| 1 month ago | $3.16 | $849.92 | -15.0% |
| 3 months ago | $3.23 | $832.82 | -16.7% |
| 6 months ago | $4.51 | $596.45 | -40.4% |
| 1 year ago | $7.39 | $364.05 | -63.6% |
| All time (4.2y) ago | $393,638.41 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACON forecast.
Our base-case forecast reaches $5.40 around 2040.
Implied market cap at $5.40: $13.3M
The multi-year forecast shows a mixed path through 2030, turning more favorable in the mid-decade and into the 2040s. In 2030, the avg price is $2.76 with a -2.9% ROI; the sentiment remains NEUTRAL. By 2033–2035 the outlook turns bullish, with 2033 avg $3.66 (ROI 28.9%), 2034 avg $3.95 (ROI 38.9%), and 2035 avg $3.77 (ROI 32.6%).
The forecast presses higher in 2040 to an avg of $5.42 (ROI 90.6%), and continues to 2050 with an avg of $7.01 (ROI 146.5%). Max forecast values reach $9.77 in 2040 and $13.98 in 2050, with bullish sentiment persisting. These are estimates and not guarantees, and they reflect the stated range of outcomes across the horizon.
Tap a question to reveal the answer.
According to the forecast, Aclarion’s average price in 2030 is $2.76 with a min of $1.97 and a max of $4.19, and an estimated ROI of -2.9%. The sentiment for 2030 is NEUTRAL.
Forecasts show a neutral stance in the near term, turning bullish from 2033 onward, with 2040 showing a strong upside (avg $5.42, ROI 90.6%) and 2050 (avg $7.01, ROI 146.5%). These are estimates and carry uncertainties; no guarantees are implied.
Yes. The forecast includes max values above $6: 2034 max $6.52, 2035 max $6.33, and later years like 2040 max $9.77 and 2050 max $13.98.
The current price is $2.84 and the market cap is $7M.
The 30-day range is between $2.29 and $3.54. The RSI(14) is 40, indicating neutral momentum, with a 50-day SMA of $3.15 and a 200-day SMA of $4.61. Support sits at $2.71 and resistance at $3.57.
Aclarion, Inc. Community Discussion
0Share your Aclarion, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.